Member Info for js1990

Target price very difficult atm.
will depend on news regarding the mask manufacturing capacities. I think this SP could explode if we can outsource manufacturing or expand our own manufacturing, or do a deal with a major player.

It is crazy! potential here will soon be found and the SP will rocket.

Remember we have the only antibody test that is going through mhra approval for self use. Our test will be the only antibody test ordered by the government as long as we can meet the demand!

He did say spring will be completely different with rapid covid tests available etc. He mentioned starting in December but imo the tests they want are the mologic and avacta LFT. Mologic are so close and ce marking in November. Seems to tie in well with the December comment from BJ. Plus they are cheap so win win!
Re rate next week. Such a safe stock to hold in times like this.

Doubt it will effect 4D. If it does great I will buy more! Gradually trying to increase my holding here whenever I get paid!
Seems to be gold and pharma companies that do well when lockdown announced and most of my portfolio is made up of gold miners and small to mid cap pharma companies with involvement in covid testing etc.
Might spend some cash getting a bit of diversity next week and buy some cheap ftse shares.

far too risky. Could get left behind. We have seen how quickly this will move upon news.
I am just holding tight!

Close at 3.8p
3-4p next week until final confirmation we own 100% pharm2farm then up up and away.
Must be some big players discussing the patent with pharm2farm now. Hopefully someone like 3m!
I only live a mile away from their office so might pop down and try and get in to see if they have purchased more equipment yet.....

You realise when you are happy with your invesement when checking the SP 4 times a day reduces to twice a week. I am not really bothered what happens to the SP now - its next year I will start looking again when we are on NASQAD £$££$£$

Just cant quite believe how this is not 70p minimum now.
As everyone has calculated our current MCAP is covered purely by our 37% holding in RMS!!! (as long as their share price is still 3p when the sale goes through).

So therefore are we saying all the other BRH investments, Paraytec, Gyrometric, Kirkstall, Senitel, Phasefocus are worth nothing!!
We have a rapid covid test, Bladder cancer test, Actipix, Quasi Vivo kit, Livecyte and wind farm monitoring systems.

All of the above are at present contributing £0 to the market cap of BRH.

I just can't wait for the market to pick up on this and see the £££ come in.

When the covid test goes to market the SP will be starting with a £ for sure!

not a bed decision.
Not a deramp as I havent sold any and still hold but may be a slight chance you can buy lower once the BRH shares hit the market and mess up the balance of the market cap.
Its a weird one as its great news that the sale has gone through so derisking but at the same time the market cap will jump by x amount due to the new shares.... Maybe they balance each other out.

Nice work! I do enjoy reading your enthusiastic posts when all my stock are red - like yesterday.

No one compares.
The two best lateral antibody test and soon the best antigen.
I sold my holding in Avacta after the presentation yesterday. I couldn't take the risk with their huge market cap and still not hearing about sensitivity of the test etc. We know from yesterday Mologic test clearly works and will be CE marked shortly.
My money is safe with ODX.

There are a couple of antigen tests which are very likely to meet sensitivity criteria but thats fine! The UK will need billions of these tests per year and theres no one 3 companies can provide the demand - Even if 10 companies came up with eligible rapid antigen tests they would all sell at their maximum manufacturing capacity.

Yeah very nicely worded RNS. I think it goes to show they are not selfish - they could quite easily take a hell of a lot more than that for what they have achieved. Shows the competence of the board.
Very happy with my investment.

I wouldn't even worry about cash raise.
If it happens in the long run it will be hugely beneficial for the company. The only reason I can see them doing one is so they can increase to 60 million masks a month not 5 million which in the long run will make the share price increase by more....significantly.
Also as existing holders we may get an opportunity to participate and buy shares through an offering.

I think the more likely approach is they get an offer from a big player and get paid royalties for the patent. Either one for me is win.

3rd option is they stick to what has already been suggested and manufacture 5 million a month which we know they can do with current funding,.

All 3 options will generate huge income and SP is only going one way. I am not worried at all.

So just to clarify do we think the antigen LFT can be sold for home use without MHRA approval as long as the government are not the main purchaser?
Would be great if this was the case and aim sales at the industries that will be big money for it - airlines, stadiums events, night clubs etc. I must admit I am quite excited for Christmas now. I'll be sat round the dining table with the family checking my phone for technical transfer confirmation ££££££

I like that! I must admit that was news to me didnt realise that!
Can you imagine the demand for the test from other countries.
Bet Trump would pay £100 per test and say anyone with the antibodies you are free to do what you want.

Minimum from now:
£10million profit from RTC Tests Average of £1 profit per test 10million tests produced per year
£4million profit from CD4 per year

Mologic antibody test+lateral flow test - assuming they average around 0.8million tests manufactured per week. Still dont know profit margins but lets say £1 per test for simplicity - £42 million profit.

total estimated profit around the £56 million per year.

Looks pretty good to be at the current MCAP. any other opinions on potential profit?

Complete technical transfer by the new year!! Wow quicker than we thought. We will beat Avacta to the market!

All great news so far!!
Can sell the RTC test to anyone we want if the UK government dont take up all the orders.
Lots of interest on the Moloigic antibody test - FDA approval in progress!
Wow I am excited!